These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35837180)

  • 1. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
    Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
    J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
    Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
    J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immunoinflammatory index and prognostic nutrition index for predicting pathologic responses of patients with advanced gastric cancer after neoadjuvant therapy for advanced gastric cancer.
    Fan M; Tang J; Du W; Du YF; Liu HJ
    Am J Cancer Res; 2024; 14(8):3922-3934. PubMed ID: 39267676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pathological tumor regression grade of lymph node metastasis following neoadjuvant chemotherapy in locally advanced gastric cancer.
    Gao B; Zhao Z; Gao X; Zhang T; Zhang N; Zhang Y; Zhu Y
    Dig Liver Dis; 2024 Oct; 56(10):1768-1775. PubMed ID: 38811246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
    Yin H; Yao Q; Xie Y; Niu D; Jiang W; Cao H; Feng X; Li Y; Li Y; Zhang X; Shen L; Chen Y
    Cancer Med; 2023 Oct; 12(19):19633-19643. PubMed ID: 37749981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    Jiang Q; Zeng X; Zhang C; Yang M; Fan J; Mao G; Shen Q; Yin Y; Liu W; Tao K; Zhang P
    World J Surg Oncol; 2022 Aug; 20(1):261. PubMed ID: 35978363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumor regression grade (TRG) after oncological gastrectomy for gastric cancer.
    Abboretti F; Mantziari S; Didisheim L; Schäfer M; Teixeira Farinha H
    Langenbecks Arch Surg; 2024 Jun; 409(1):199. PubMed ID: 38935163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
    Clin Transl Oncol; 2023 Aug; 25(8):2462-2471. PubMed ID: 37093455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy.
    Tong Y; Zhu Y; Zhao Y; Jiang C; Wang W; Shan Z; Sun F; Liu D; Zhang J
    J Cancer; 2021; 12(21):6465-6472. PubMed ID: 34659537
    [No Abstract]   [Full Text] [Related]  

  • 11. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
    Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
    Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
    Tong Y; Zhao Y; Shan Z; Zhang J
    BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?
    Ma F; Zhang Y; Peng L; Zhang Z; Yang W; Chai J; Zhang B; Ji S; Hua Y; Chen X; Luo S
    Ann Transl Med; 2020 Aug; 8(15):948. PubMed ID: 32953748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
    Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
    Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
    Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohort.
    Jiang Q; Liu W; Zeng X; Zhang C; Du Y; Zeng L; Yin Y; Fan J; Yang M; Tao K; Zhang P
    Front Immunol; 2023; 14():1122121. PubMed ID: 37215127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Regression Grade Predicts Survival in Locally Advanced Gastric Adenocarcinoma Patients with Lymph Node Metastasis.
    Tong Y; Zhu Y; Zhao Y; Shan Z; Zhang J; Liu D
    Gastroenterol Res Pract; 2020; 2020():3435673. PubMed ID: 32733550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
    Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Obesity on Response to Neoadjuvant Therapy in Locally Advanced Gastric Cancer.
    Sakin A; Sahin S; Sakin A; Aldemir MN; Bayram I; Kotan C
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2723-2731. PubMed ID: 32986374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.